Compare DNUT & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DNUT | BME |
|---|---|---|
| Founded | 1937 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Trusts Except Educational Religious and Charitable |
| Sector | Consumer Staples | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 585.5M | 547.5M |
| IPO Year | 2021 | 2005 |
| Metric | DNUT | BME |
|---|---|---|
| Price | $3.55 | $39.80 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $4.72 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 49.0K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.01% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,522,616,000.00 | N/A |
| Revenue This Year | $0.55 | N/A |
| Revenue Next Year | $3.59 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.58 | $35.03 |
| 52 Week High | $5.73 | $42.74 |
| Indicator | DNUT | BME |
|---|---|---|
| Relative Strength Index (RSI) | 56.55 | 51.22 |
| Support Level | $3.46 | $37.71 |
| Resistance Level | $3.87 | $42.34 |
| Average True Range (ATR) | 0.14 | 0.89 |
| MACD | 0.01 | 0.25 |
| Stochastic Oscillator | 74.42 | 76.39 |
Krispy Kreme Inc is a sweet-treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations world-wide. It derives maximum revenue from the U.S. segment.
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.